(which operates as Hims and Hers) Location: San Francisco, CaliforniaStore Websites: and Letter Date: September 9, 2025FDA Department issuing Warning: Center for Drug Evaluation and Research (CDER)Types of Products Sold: Prescribes and sells compounded semaglutide, tirzepatide and other compounded productsType of Warning: Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the InternetFDA Warning: The website makes false claims about compounded drug products, including: Same active ingredient as Ozempic and Wegovy and Clinically proven ingredients. The claims imply that the products are the same as an FDA-approved product when they are not
You pay us what you see on your invoice, for example, Goods Subtotal + Shipping Costs (does not include duties)
The complete BPC-157 TB-500 blend guide covers combination protocols in detail
Giunchi, V., Fusaroli, M., Hauben, M., Raschi, E